Panacea Announces Collaboration With MIT

panacea-pharmaceuticalsPanacea Pharmaceuticals, Inc. has signed a Collaborative Research Agreement with researchers at the (MIT) in Cambridge, Massachusetts covering the development of all-human, ultra-affinity, single-chain antibodies for its cancer platform technology.

The research group is led by K. Dane Wittrup, Ph.D., J.R. Mares Professor of Chemical Engineering and Bioengineering at MIT. Dr. Wittrup stated, “We are excited to be collaborating with Panacea to develop these novel molecules. Panacea’s cancer technology provides an extraordinary treatment and diagnostic approach that is well-suited to utilize all of the diverse applications of our technology.”

The Company’s cancer platform technology is based on the enzyme aspartyl asparaginyl-Beta hydroxylase (AAH), which the Company has an exclusive worldwide license from Rhode Island Hospital/Brown University.

AAH’s utility as a drug target has been shown in published studies, which have demonstrated that the over expression of AAH leads to the transformation of normal cells to cancer cells in liver, brain, colon, pancreatic, and breast cancers.

“We have now set into action a multi-tiered approach to developing drugs for our cancer platform technology, namely the development of novel antibody drugs, traditional small molecules, and antisense oligonucleotides that treat disease at the gene,” stated Kasra Ghanbari, Chief Operating Officer of the Company.

, Inc. focuses on developing and utilizing protein-based technologies to detect and identify changes associated with and involved in diseases of the central nervous system and cancer such as ‘s disease, brain tumors, transmissible spongiform encephalopathies, and Lewy body diseases such as Parkinson’s disease.


Dragon Pharma is a pharmaceutical company: Legal TriTren 150 On-Line – manufacturing and exporting from Europe.

Acquire Dragon Pharma LLC Legally

Oxymetholon - Bulk Price

Administration: Oral
Basal Ingredient: Oxymetholone
Producer: Dragon Pharma LLC
Package: 10 x 100 tablets (50 mg/tablet)
Price: 10 x $65.00

TriTren 150 - Bulk Price

Administration: Injection
Basal Component: Tri Trenbolone
Made by: Dragon Pharmaceuticals
Pack: 10 x 10 mL vial (150 mg/mL)
Price: 10 x $72.00

Trenbolone 100 - Bulk Price

Administration: Injection
Active Constituent: Trenbolone Acetate
Manufacturer: Dragon Pharmaceutical
Package: 10 x 10 mL vial (100 mg/mL)
Price: 10 x $60.00

Enantat 250 - Discount Price

Administration: Injection
Principal Substance: Testosterone Enanthate
Manufacturer: Dragon Pharma LLC
Unit: 30 x 10 mL vial (250 mg/mL)
Price: 30 x $25.00

Nolvadex - Bulk Price

Administration: Oral
Base Constituent: Tamoxifen Citrate
Produced by: Dragon Pharma
Package: 10 x 100 tablets (20 mg/pastille)
Price: 10 x $40.00

Trenbolone 100

Injectable Anabolic Steroid
Active Chemical Name: Trenbolone Acetate
Producer: Dragon Pharma Labs
Amount: 1 X 10 ml (100 mg/ml)

Dianabol 20 - Bulk Price

Administration: Oral
Primary Ingredient: Methandrostenolone
Manufacturer: Dragon Pharmaceuticals
Amount: 10 x 100 pills (20 mg/pastille)
Price: 10 x $39.00

Trenbolone 100 - Cheap Price

Administration: Injection
Base Constituent: Trenbolone Acetate
Made by: Dragon Pharmaceutical
Package: 20 x 10 mL vial (100 mg/mL)
Price: 20 x $52.00


Selective Estrogen Receptor Modulator
Prime Chemical Name: Clomiphene Citrate
Manufacturer: Dragon Pharmaceuticals
Unit: 1 X 100 tabs (50 mg/tab)

Cut Mix 150 - Bulk Price

Administration: Injection
Main Substance: Testosterone Propionate, Drostanolone Propionate, Trenbolone Acetate
Produced by: Dragon Pharma LLC
Amount: 10 x 10 mL vial (150 mg/mL)
Price: 10 x $52.00

Enantat 400

Injectable Anabolic Steroid
Main Constituent: Testosterone Enanthate
Branded by: Dragon Pharmaceutical
Unit: 1 X 10 ml (400 mg/ml)


Synthetic Anabolic Steroidal Agent
Active Substance: Oxandrolone
Producer: Dragon Pharma LLC
Package: 1 X 100 tablets (50 mg/tablet)